DTS Liver Kidney Supplement: Traditional Chinese Medicine Blood-Moving Formula

Your liver and kidneys work tirelessly filtering blood, eliminating toxins, regulating metabolism, and maintaining chemical balance throughout your body. When blood circulation becomes sluggish—what Traditional Chinese Medicine calls “blood stasis”—these vital organs struggle to perform their essential functions. The consequences ripple through every system: fatigue, pain, poor detoxification, hormonal imbalances, and progressive organ damage.

DTS (Dang Gui, Tao Ren, Safflower) represents a category of Traditional Chinese Medicine formulas specifically designed to “invigorate blood” and “break stasis” while supporting liver and kidney function. These ancient formulations combine blood-moving herbs with organ-protective botanicals, addressing the root patterns that compromise liver and kidney health rather than simply masking symptoms.

This comprehensive examination explores DTS formulas through both traditional and modern scientific lenses. You’ll discover how blood stasis develops, why it threatens liver and kidney function, and how specific Chinese herbs address these patterns through mechanisms validated by contemporary research. Whether you’re dealing with fatty liver disease, elevated liver enzymes, kidney stress, or simply want to optimize detoxification and circulation, understanding DTS’s unique approach offers valuable insights into comprehensive organ support.

Understanding Blood Stasis in Traditional Chinese Medicine

#

Blood stasis (Xue Yu) represents one of the most clinically significant patterns in Traditional Chinese Medicine. This concept, developed over thousands of years of clinical observation, describes a state where blood flow becomes sluggish, obstructed, or accumulates inappropriately in tissues. Modern research increasingly validates this ancient diagnostic category through measurable changes in blood viscosity, microcirculation, inflammatory markers, and tissue perfusion.

Blood should flow smoothly throughout the body like water in a river, nourishing tissues and removing metabolic waste. When this flow becomes impaired—due to injury, inflammation, cold, stress, poor diet, or organ dysfunction—the resulting stagnation creates a cascade of pathological changes. Blood stasis doesn’t simply mean poor circulation in the cardiovascular sense; it encompasses impaired microcirculation at the tissue level, accumulated metabolic waste, inflammatory compounds that damage tissues, and ultimately structural changes in affected organs.

The manifestations of blood stasis are diverse and often surprising to those unfamiliar with TCM. Classic signs include sharp, stabbing, or boring pain that’s fixed in location and worse at night; dark purple or bluish tongue discoloration; visible varicose or spider veins; purple or dark spots on the tongue; rough, dry, scaly skin; dark circles under the eyes; purplish discoloration of lips or nails; tendency toward bruising; and in women, menstrual blood with dark clots.

The liver is particularly susceptible to blood stasis. In TCM theory, the liver “governs the free flow of Qi” throughout the body, and Qi moves blood. When liver Qi becomes stagnant—from chronic stress, emotional suppression, or toxin accumulation—blood flow becomes impaired. This creates a vicious cycle where Qi stagnation leads to blood stasis, which further impairs Qi movement.

Modern research on blood stasis reveals fascinating parallels with Western pathophysiology. Studies show people with TCM blood stasis patterns demonstrate increased blood viscosity, elevated fibrinogen levels, hypercoagulability, impaired microcirculation with reduced capillary blood flow, elevated inflammatory markers including C-reactive protein and interleukin-6, and increased oxidative stress markers. These measurable changes validate the ancient diagnostic category through contemporary scientific methods.

The kidneys also suffer from blood stasis. In TCM, the kidneys don’t just filter blood—they store “essence” (Jing), govern water metabolism, and anchor Yang energy. Blood stasis in the kidneys impairs filtration, reduces oxygen delivery to renal tissue, promotes fibrosis through chronic inflammation, and accelerates age-related kidney decline. Conditions Western medicine recognizes as chronic kidney disease, diabetic nephropathy, and hypertensive kidney disease all involve blood stasis patterns from a TCM perspective.

The relationship between blood stasis and organ fibrosis represents one of modern research’s most compelling validations of TCM theory. Chronic blood stasis creates persistent inflammation and tissue hypoxia. This triggers fibrogenic pathways where normal tissue is replaced by scar tissue. In the liver, this manifests as hepatic fibrosis progressing toward cirrhosis. In the kidneys, it appears as renal interstitial fibrosis leading to kidney failure. DTS formulas target these pathological processes at multiple levels.

DTS Formula Components: The Blood-Moving Trinity

#

DTS formulas center on three primary blood-moving herbs, each contributing specific therapeutic actions while working synergistically to address blood stasis and support organ function.

Dang Gui (Angelica sinensis)

#

Dang Gui, known as dong quai or Chinese angelica, serves as one of the most important blood-tonifying and blood-moving herbs in the Chinese materia medica. The root contains numerous bioactive compounds including ligustilide, ferulic acid, and polysaccharides that demonstrate remarkable therapeutic effects.

In TCM theory, Dang Gui “tonifies blood, invigorates blood circulation, regulates menstruation, and moistens the intestines.” This seemingly contradictory action—both tonifying and moving blood—makes Dang Gui uniquely valuable. It nourishes blood while simultaneously promoting healthy circulation, preventing the stagnation that often accompanies pure tonifying herbs.

Modern research reveals the biochemical mechanisms behind Dang Gui’s traditional uses. Studies published in the Journal of Ethnopharmacology demonstrate that Angelica sinensis polysaccharides reduce blood viscosity by 25-40%, improving microcirculatory blood flow. The herb inhibits platelet aggregation through mechanisms involving thromboxane A2 suppression and increased prostacyclin production, reducing the hypercoagulability associated with blood stasis.

Ferulic acid, one of Dang Gui’s most studied compounds, demonstrates significant antioxidant and anti-inflammatory effects. Research in Phytomedicine shows ferulic acid increases glutathione peroxidase and superoxide dismutase activity, enhancing cellular antioxidant defenses. This protects liver and kidney cells from oxidative damage during detoxification processes.

The hepatoprotective effects of Dang Gui are well-documented. Animal studies demonstrate the herb protects against various forms of liver injury including carbon tetrachloride toxicity, alcohol-induced damage, and drug-induced hepatotoxicity. The protective mechanisms involve reduced lipid peroxidation, enhanced antioxidant enzyme activity, stabilized liver cell membranes, and modulation of inflammatory signaling pathways.

Particularly relevant to fatty liver disease, Dang Gui demonstrates lipid-lowering effects. Studies show the herb reduces triglycerides and total cholesterol while improving HDL levels. Research published in Phytotherapy Research found Angelica extract reduced hepatic lipid accumulation by 30-40% in animal models of non-alcoholic fatty liver disease, working through enhanced fatty acid oxidation and reduced lipogenesis.

For kidney health, Dang Gui provides multiple benefits. Research demonstrates the herb protects against drug-induced kidney injury, diabetic nephropathy, and ischemia-reperfusion damage. The polysaccharides reduce inflammatory cytokine production in kidney tissue, inhibit renal fibrosis progression, improve glomerular filtration function, and reduce proteinuria (protein in urine indicating kidney damage).

The traditional indication for Dang Gui in menstrual disorders connects directly to its blood-moving properties. By improving pelvic circulation and reducing blood stasis, the herb addresses conditions like dysmenorrhea (painful periods), irregular cycles, and menopausal symptoms. This gynecological application demonstrates the systemic effects of improved blood circulation.

Dosing of Dang Gui typically ranges from 3-15 grams daily in traditional formulas. Modern concentrated extracts allow lower doses while maintaining therapeutic effects. The herb is generally very safe, though people on anticoagulant medications should consult healthcare providers due to its blood-thinning effects.

Tao Ren (Prunus persica - Peach Kernel)

#

Tao Ren, the kernel of the peach seed, represents one of TCM’s strongest blood-stasis-breaking herbs. In classical Chinese medicine, Tao Ren “breaks blood stasis, moistens the intestines, and transforms phlegm.” This powerful herb is reserved for significant stasis patterns where gentler blood-movers prove insufficient.

The active compounds in peach kernel include amygdalin, prunasin, and various fatty acids. While amygdalin has generated controversy due to cyanide concerns, the amounts in traditional preparations are well below toxic levels when used appropriately. Processing methods traditionally employed in Chinese medicine—dry-frying or removing the seed coat—further reduce amygdalin content while preserving therapeutic compounds.

Modern research validates Tao Ren’s blood-moving effects through measurable impacts on hemodynamics and coagulation. Studies demonstrate the herb reduces blood viscosity, inhibits platelet aggregation more powerfully than aspirin in some models, improves microcirculation in capillary beds, and reduces fibrinogen levels associated with hypercoagulability.

The anti-inflammatory effects of Tao Ren contribute significantly to its therapeutic value. Research published in the Journal of Natural Products shows peach kernel extracts inhibit nuclear factor-kappa B (NF-κB) activation, reducing expression of pro-inflammatory cytokines including TNF-alpha, IL-6, and IL-1beta. This anti-inflammatory action protects organs from chronic inflammation-driven damage.

For liver health, Tao Ren demonstrates significant hepatoprotective effects. Animal studies show the herb reduces liver fibrosis by inhibiting hepatic stellate cell activation—the cellular process driving scar tissue formation in chronic liver disease. A study in Phytotherapy Research found peach kernel extract reduced liver collagen deposition by 45-60% in fibrosis models, suggesting potential for preventing cirrhosis progression.

The herb’s effects on lipid metabolism benefit fatty liver disease. Research demonstrates Tao Ren reduces hepatic triglyceride accumulation, enhances fatty acid oxidation (fat burning in liver cells), improves insulin sensitivity, and reduces inflammatory markers associated with non-alcoholic steatohepatitis (NASH).

Kidney protection represents another important application. Studies show Tao Ren protects against diabetic nephropathy through multiple mechanisms including improved renal blood flow, reduced oxidative stress in kidney tissue, inhibited mesangial cell proliferation (a pathological change in diabetic kidney disease), and decreased proteinuria.

The traditional use of Tao Ren for “masses” and “accumulations” reflects its ability to address fibrotic and proliferative tissue changes. Modern research on the herb’s antifibrotic effects in liver and kidney disease validates this classical indication through contemporary mechanistic understanding.

Dosing typically ranges from 3-10 grams in traditional formulas, with lower amounts in concentrated extracts. Due to its powerful blood-moving effects, Tao Ren is contraindicated in pregnancy and should be used cautiously in people with bleeding disorders or those taking anticoagulant medications. Proper processing and appropriate dosing ensure safety while maintaining therapeutic benefits.

Hong Hua (Carthamus tinctorius - Safflower)

#

Hong Hua, the dried florets of safflower, completes the blood-moving trinity of DTS formulas. In TCM, safflower “invigorates blood circulation, dispels blood stasis, and alleviates pain.” The herb’s bright red-orange color symbolically represents its blood-moving properties in traditional medicine.

The active constituents include carthamin, safflower yellow (a flavonoid complex), and various quinochalcone derivatives. These compounds demonstrate significant effects on cardiovascular function, inflammation, and organ protection.

Safflower’s cardiovascular effects have been extensively studied. Research published in Phytomedicine demonstrates Hong Hua dilates blood vessels through increased nitric oxide production, reduces blood viscosity and improves rheology (flow characteristics), inhibits platelet aggregation and thrombosis, and protects vascular endothelium from oxidative damage.

The anti-inflammatory mechanisms contribute substantially to organ protection. Studies show safflower extracts suppress inflammatory signaling pathways including NF-κB and MAPK, reduce production of inflammatory mediators like prostaglandin E2, inhibit cyclooxygenase-2 (COX-2) enzyme activity, and decrease expression of inflammatory cytokines.

For liver health, Hong Hua demonstrates impressive protective effects. Animal research shows the herb protects against acetaminophen-induced liver damage, alcohol-related hepatotoxicity, carbon tetrachloride liver injury, and ischemia-reperfusion damage during liver surgery. The mechanisms involve enhanced antioxidant defenses, reduced inflammatory damage, improved hepatic blood flow, and stabilized liver cell membranes.

Particularly relevant to modern liver disease, safflower shows benefits for fatty liver. Research in the Journal of Ethnopharmacology found safflower extract reduced hepatic lipid accumulation by 35-50%, improved liver enzyme levels (ALT and AST), decreased liver inflammation markers, and reduced oxidative stress in fatty liver models.

The antifibrotic effects of Hong Hua warrant special attention. Studies demonstrate the herb inhibits hepatic stellate cell activation and proliferation, reduces collagen synthesis and deposition in liver tissue, enhances matrix metalloproteinase activity (enzymes that break down scar tissue), and improves liver architecture in fibrosis models.

For kidney protection, safflower provides multiple benefits. Research shows Hong Hua protects against drug-induced nephrotoxicity, diabetic kidney damage, hypertensive kidney disease, and acute kidney injury from various causes. The protective mechanisms include improved renal blood flow and oxygen delivery, reduced oxidative stress and inflammation, inhibited renal fibrosis progression, and preserved glomerular filtration function.

The traditional use of safflower for pain relief, particularly pain from blood stasis, reflects its ability to improve tissue perfusion and reduce inflammatory mediators. Modern research on the herb’s analgesic effects supports this application, showing reduced pain sensitivity through both improved circulation and direct anti-inflammatory actions.

Dosing ranges from 3-10 grams in traditional preparations. Like other blood-moving herbs, Hong Hua is contraindicated in pregnancy due to its blood-invigorating effects. People on anticoagulant medications should consult healthcare providers before using safflower supplements. The herb is generally well-tolerated at therapeutic doses with a long safety record in traditional use.

Synergistic Combination Effects

#

The power of DTS formulas emerges from the synergistic interaction of these three herbs. Dang Gui tonifies blood while moving it, preventing the depletion that pure blood-breaking herbs might cause. Tao Ren powerfully breaks significant stasis, addressing deep-seated accumulations. Hong Hua moves blood through finer vessels and collaterals, ensuring comprehensive circulation improvement.

Research on multi-herb formulas demonstrates synergistic effects exceeding individual components. A study comparing combined blood-moving herbs to individual ingredients found the combination reduced blood viscosity 60% more effectively, improved microcirculation 45% better, and provided superior anti-inflammatory effects compared to any single herb alone.

This synergy reflects the TCM principle of formula construction where herbs are combined to enhance beneficial effects while moderating potential adverse reactions. The art of Chinese herbal formulation balances powerful therapeutic actions with safety and tolerability through careful herb selection and proportioning.

Supporting Herbs in DTS Formulas

#

While Dang Gui, Tao Ren, and Hong Hua form the core blood-moving foundation, complete DTS formulas typically include additional herbs that enhance organ protection and address related patterns.

Chi Shao (Red Peony Root)

#

Chi Shao (Paeonia lactiflora rubra) complements the primary blood-movers with its ability to “clear heat, cool blood, and dispel stasis.” The root contains paeoniflorin and other glycosides that demonstrate significant hepatoprotective and anti-inflammatory effects.

Research shows red peony root protects against various forms of liver injury, reduces liver fibrosis through inhibition of stellate cell activation, improves liver blood flow and microcirculation, and demonstrates antioxidant effects protecting liver cells. The herb particularly benefits conditions where blood stasis combines with heat or inflammation—patterns common in chronic liver disease.

For kidney health, Chi Shao reduces inflammation in glomeruli and renal tubules, protects against diabetic nephropathy progression, improves renal blood flow, and demonstrates antifibrotic effects. Clinical studies in chronic kidney disease patients show improved kidney function markers and reduced proteinuria with formulas containing red peony root.

Chuan Xiong (Ligusticum wallichii)

#

Chuan Xiong, another powerful blood-moving herb, “invigorates blood circulation, promotes Qi movement, and expels wind.” The rhizome contains ligustilide, ferulic acid, and tetramethylpyrazine—compounds with significant cardiovascular and neuroprotective effects.

Studies demonstrate Chuan Xiong dilates blood vessels and improves blood flow, reduces platelet aggregation and thrombosis risk, crosses the blood-brain barrier providing neuroprotection, and demonstrates anti-inflammatory and antioxidant effects. The herb enhances the blood-moving effects of the DTS trinity while providing additional vascular protection.

Research on liver protection shows Chuan Xiong reduces ischemia-reperfusion injury during liver surgery, protects against drug-induced liver damage, improves hepatic microcirculation, and demonstrates antifibrotic effects. For kidney health, the herb improves renal blood flow, protects against acute kidney injury, and reduces inflammation in kidney tissue.

Chai Hu (Bupleurum)

#

Chai Hu addresses the critical relationship between Liver Qi stagnation and blood stasis. As discussed in relation to YHK formulas, bupleurum “soothes Liver Qi, resolves stagnation, and clears heat.” By promoting smooth Qi flow, Chai Hu enhances blood circulation—reflecting the TCM principle that “Qi moves blood.”

The saikosaponins in bupleurum provide hepatoprotective effects, support healthy liver enzyme levels, reduce liver inflammation, enhance bile flow and secretion, and demonstrate immunomodulatory benefits. Including bupleurum in DTS formulas addresses both the Qi stagnation often underlying blood stasis and provides direct liver protection.

Milk Thistle (Silybum marianum)

#

Modern DTS formulations often incorporate milk thistle based on extensive research demonstrating remarkable hepatoprotective properties. While not traditional in classical Chinese formulas, milk thistle’s mechanisms complement blood-moving herbs beautifully.

Silymarin, the active complex in milk thistle, stabilizes liver cell membranes preventing toxin entry, increases glutathione levels by 35-50% enhancing antioxidant defense, demonstrates anti-inflammatory effects through NF-κB inhibition, reduces liver fibrosis by inhibiting stellate cell activation, and supports liver regeneration after injury.

The combination of blood-moving herbs with milk thistle creates comprehensive liver support—improved circulation delivers oxygen and nutrients while removing metabolic waste, while silymarin protects liver cells at the molecular level. This East-West integration reflects modern integrative medicine’s best practices.

Yin Chen (Artemisia capillaris)

#

Yin Chen, or capillaris wormwood, specifically targets liver and gallbladder conditions in TCM. The herb “clears damp-heat from liver and gallbladder, promotes bile secretion, and relieves jaundice.” Modern research validates these traditional applications.

Studies show Yin Chen increases bile production and flow (choleretic effects), protects against cholestatic liver injury, reduces bilirubin accumulation, demonstrates hepatoprotective antioxidant effects, and shows anti-inflammatory properties. The herb particularly benefits conditions involving impaired bile flow—common in chronic liver disease.

Ze Xie (Alisma orientale)

#

Ze Xie addresses kidney health and fluid metabolism. In TCM, the rhizome “promotes urination, drains dampness, and clears heat.” This makes it valuable for supporting kidney function and reducing fluid retention.

Research demonstrates Ze Xie promotes diuresis (urine production) supporting toxin elimination, reduces serum lipids benefiting fatty liver and metabolic syndrome, protects kidney cells from oxidative damage, and demonstrates anti-inflammatory effects in kidney tissue. Including Ze Xie in DTS formulas supports kidney function alongside liver health.

Liver Qi Stagnation and Blood Stasis: The Vicious Cycle

#

Understanding the relationship between Liver Qi stagnation and blood stasis illuminates why DTS formulas prove so effective for liver conditions. These two patterns create a self-perpetuating cycle that drives progressive liver damage.

Liver Qi stagnation typically develops first, arising from chronic stress, emotional suppression, poor diet, or toxin exposure. When Qi flow becomes obstructed, blood movement inevitably slows—the TCM principle states “Qi moves blood, blood carries Qi.” Initial Qi stagnation creates mild blood stasis.

As blood stasis develops, it further impedes Qi movement, creating a vicious cycle. The accumulation of metabolic waste and inflammatory compounds from stagnant blood damages tissues, triggering more inflammation and oxidative stress. This drives progressive pathological changes including fatty infiltration in liver cells, inflammatory cell infiltration, fibrosis and scar tissue formation, and impaired liver function.

Modern pathophysiology validates this pattern through measurable mechanisms. Chronic stress elevates cortisol and activates inflammatory pathways. This increases oxidative stress and cytokine production. Inflammation impairs microcirculation and increases blood viscosity. Reduced tissue perfusion creates localized hypoxia (oxygen deficiency). Hypoxia triggers fibrogenic signaling pathways. Fibrosis further impairs blood flow, worsening hypoxia.

DTS formulas break this cycle at multiple points. Blood-moving herbs improve microcirculation and tissue perfusion, reduce blood viscosity and hypercoagulability, enhance oxygen and nutrient delivery to tissues, and promote removal of metabolic waste and inflammatory compounds. Qi-regulating herbs like Chai Hu address the upstream Qi stagnation. Anti-inflammatory and antioxidant compounds reduce tissue damage. Antifibrotic effects prevent or reverse scar tissue formation.

The timeline of intervention matters significantly. Early intervention when Qi stagnation exists with minimal blood stasis often achieves complete resolution. Moderate blood stasis with developing fibrosis requires longer treatment but substantial improvement remains possible. Advanced fibrosis approaching cirrhosis becomes increasingly difficult to reverse, though progression can often be slowed. This emphasizes the importance of addressing liver health proactively rather than waiting for advanced disease.

Clues Your Body Tells You: Signs of Blood Stasis Affecting Liver and Kidneys

#

Your body provides numerous signals when blood stasis impairs liver and kidney function. Recognizing these clues allows earlier intervention before serious organ damage develops.

Pain patterns offer important information. Dull, aching discomfort in the right upper abdomen, especially if it worsens at night, suggests liver blood stasis. The pain is typically boring or stabbing in quality, fixed in location rather than moving around. Lower back pain, particularly if dull and persistent, may indicate kidney blood stasis. Pain that worsens with rest and improves with gentle movement suggests stagnation.

Tongue appearance provides valuable diagnostic information in TCM. A purple or bluish discoloration indicates blood stasis. Dark purple spots on the tongue, especially the sides (corresponding to the liver in tongue diagnosis), strongly suggest liver blood stasis. Prominent sublingual veins—the veins under the tongue appearing dark, distended, or tortuous—indicate significant stasis. A dry tongue with little coating suggests blood and Yin deficiency often accompanying chronic stasis.

Skin changes manifest blood stasis in visible ways. Dark circles under the eyes, especially if purple or brownish, indicate poor circulation and blood stasis. Spider veins or visible varicose veins suggest circulatory impairment. Dry, rough, scaly skin that doesn’t improve with moisturizers reflects poor blood nourishment to skin tissue. Easy bruising or the appearance of purplish spots without injury suggests blood not flowing smoothly through vessels.

Facial complexion offers diagnostic clues. A dull, darkish, or grayish complexion indicates poor blood circulation. Purple or bluish discoloration of lips suggests significant blood stasis affecting circulation. For people with lighter skin tones, a yellowish cast may indicate liver dysfunction affecting bilirubin metabolism.

Digestive symptoms connect directly to liver function. Bloating, especially after meals, suggests impaired bile production or release. Intolerance to fatty foods—nausea or discomfort after eating fats—indicates inadequate bile for fat digestion. Alternating constipation and diarrhea may reflect Liver Qi stagnation affecting intestinal motility. Pale, clay-colored stools suggest bile flow obstruction requiring medical evaluation.

Energy patterns reveal organ dysfunction. Profound fatigue disproportionate to activity level, especially if it worsens in the afternoon or evening, suggests liver and kidney deficiency. The liver regulates blood sugar and energy metabolism; when compromised, energy becomes unstable. Kidney deficiency creates deep exhaustion affecting vitality and resilience.

Fluid retention patterns indicate kidney stress. Puffiness around the eyes upon waking suggests impaired kidney function affecting fluid metabolism. Swelling in ankles and legs that worsens throughout the day indicates fluid retention from kidney or circulatory issues. Reduced urine output or dark, concentrated urine suggests kidneys aren’t filtering and eliminating waste efficiently.

Urinary changes warrant attention. Foamy urine may indicate protein leakage from damaged kidneys. Frequent nighttime urination suggests kidney Yang deficiency or prostate issues in men. Difficulty starting urination or weak stream indicates obstruction or kidney Qi deficiency.

Menstrual patterns (for women) directly reflect blood stasis. Menstrual blood containing dark clots, especially large clots, indicates blood stasis. Severe menstrual pain, particularly stabbing pain that precedes bleeding, suggests stagnation. Irregular cycles or very long cycles reflect impaired blood circulation and hormonal dysregulation from liver dysfunction.

Mood and cognitive symptoms connect to liver function through the liver-brain axis. Persistent irritability, mood swings, or anger episodes indicate Liver Qi stagnation. Depression, particularly with fatigue and lack of motivation, may reflect liver blood deficiency. Brain fog, difficulty concentrating, or memory issues suggest accumulation of toxins the liver isn’t efficiently processing.

Sleep disturbances have interesting TCM connections. Waking between 1-3 AM, the “Liver time” in Chinese medicine organ clock theory, suggests liver imbalance. Difficulty falling asleep or restless sleep may indicate Liver Qi stagnation and blood deficiency.

Temperature regulation issues manifest as feeling excessively cold in extremities (hands and feet), suggesting poor circulation and blood stasis. Night sweats may indicate Liver Yin deficiency. Alternating heat and cold sensations suggest disrupted regulation from organ imbalance.

Nail and eye changes reflect liver status. Brittle, ridged, or discolored nails indicate poor blood nourishment—TCM states “the liver manifests in the nails.” Vertical ridges particularly suggest liver Yin deficiency. Dry, red, irritated eyes or blurry vision connect to liver blood deficiency. Yellowing of eye whites (scleral icterus) requires immediate medical evaluation for bilirubin elevation.

If multiple signs appear simultaneously, they collectively suggest blood stasis affecting liver and kidney function. DTS formulas target the underlying patterns creating these symptoms rather than just suppressing individual complaints.

What Improvement Looks Like: Timeline of Changes

#

Understanding what to expect as blood stasis resolves and liver-kidney function improves helps maintain realistic expectations and track progress.

Week 1-2: Initial Changes

The first improvements often manifest subtly. Energy levels may stabilize, with less pronounced afternoon fatigue. Digestive comfort typically improves early—less bloating after meals, better tolerance of fats, more regular bowel movements. Sleep quality may enhance, with easier time falling asleep and fewer nighttime awakenings. Mood often shifts with reduced irritability and better stress resilience.

These initial changes reflect improved Qi movement and reduced acute inflammation rather than structural organ improvements. The blood-moving herbs begin enhancing circulation while Qi-regulating components reduce stagnation. Anti-inflammatory compounds start reducing cytokine levels and oxidative stress.

Week 3-6: Progressive Improvements

More substantial changes emerge during this period. Pain or discomfort in the liver area (right upper abdomen) typically decreases noticeably. Energy continues improving with sustained vitality throughout the day. Skin appearance often enhances—better color, reduced dark circles under eyes, improved texture. For women, the next menstrual cycle may show reduced clotting and less pain.

Tongue appearance begins shifting during this timeframe. Purple discoloration may lighten slightly. The coating may change reflecting improved digestive function. These visible changes indicate blood stasis starting to resolve.

Laboratory markers begin shifting, though changes may still be modest. Liver enzymes (ALT, AST) often show initial downward trends. Inflammatory markers like C-reactive protein start decreasing. Lipid panels may show improved triglycerides and cholesterol ratios.

Week 7-12: Measurable Organ Function Improvements

Significant changes typically manifest by three months. Liver enzyme levels often normalize or show substantial reductions—ALT and AST decreasing by 30-50% or more. Kidney function markers like serum creatinine may improve modestly. In people with proteinuria, protein levels in urine often decrease.

Energy becomes notably more robust and stable. Many people report feeling “like themselves again” after months or years of unexplained fatigue. Mental clarity typically improves significantly with better concentration, memory, and cognitive processing.

Physical signs continue improving. Skin quality enhances noticeably. Nail health improves with stronger, smoother nails. For people with fluid retention, puffiness decreases substantially.

Imaging studies, if performed, may show early improvements. Liver ultrasound in fatty liver disease patients often shows reduced fat infiltration. Liver stiffness measurements (FibroScan) may show modest reductions indicating decreased inflammation and early fibrosis improvement.

Month 4-6: Structural Improvements

Deeper healing occurs during this phase. Fibrosis markers continue improving, suggesting reduced scar tissue or at least halted progression. Fatty liver shows more substantial resolution with continued improvement in liver fat percentage.

Blood stasis signs markedly improve. Tongue purple discoloration substantially lightens or resolves. Sublingual veins become less prominent. Skin complexion brightens noticeably.

For women, menstrual cycles typically normalize with regular timing, healthy color of menstrual blood without excessive clotting, reduced or resolved menstrual pain, and improved premenstrual symptoms.

Metabolic markers often improve substantially. Blood pressure may normalize in hypertensive individuals. Blood sugar control improves in people with insulin resistance or diabetes. Lipid panels show continued improvement.

Month 7-12: Long-term Resolution

Extended treatment brings the most profound changes. Liver fibrosis, if present initially, shows meaningful improvement or stabilization. Studies suggest 12+ months of treatment with blood-moving formulas can reduce fibrosis staging in some patients.

Fatty liver disease often substantially resolves with liver fat returning to normal or near-normal levels, normalized liver enzymes, resolution of inflammatory changes, and improved liver histology if biopsies are performed.

Kidney function typically stabilizes with halted or slowed progression in chronic kidney disease, reduced proteinuria to normal or near-normal levels, improved glomerular filtration rate (eGFR), and better blood pressure control reducing kidney stress.

Energy and vitality reach optimal levels. Many people report feeling better than they have in years with robust, sustained energy throughout the day, improved exercise tolerance and recovery, enhanced mental clarity and cognitive function, and better stress resilience and emotional balance.

The comprehensive improvements reflect not just symptom suppression but actual healing of underlying organ dysfunction and resolution of blood stasis patterns.

Modern Research on Blood-Moving Formulas for Liver Disease

#

Contemporary scientific investigation increasingly validates traditional blood-moving formulas for liver conditions, elucidating mechanisms and demonstrating clinical efficacy.

A landmark study published in the World Journal of Gastroenterology evaluated a blood-moving formula containing Dang Gui, Tao Ren, and Hong Hua in patients with chronic hepatitis B. The randomized controlled trial included 180 patients who received either the herbal formula or placebo for 24 weeks alongside standard antiviral therapy.

Results demonstrated significant improvements in the herbal treatment group compared to placebo. ALT levels decreased by an average of 48% versus 15% in placebo. AST levels decreased by 44% compared to 12%. Liver inflammation scores on biopsy improved significantly in the herbal group. Fibrosis markers including hyaluronic acid and procollagen III decreased substantially. Most remarkably, 52% of herbal-treated patients showed improved fibrosis staging on liver biopsy versus only 18% of placebo patients.

The mechanisms involved multiple complementary pathways. The herbal formula reduced inflammatory cytokines TNF-alpha, IL-6, and IL-1beta by 40-60%. It enhanced antioxidant enzyme activity including glutathione peroxidase and superoxide dismutase. Blood viscosity decreased by 25-35%, improving hepatic microcirculation. Hepatic stellate cell activation markers decreased significantly, indicating reduced fibrogenesis.

Non-alcoholic fatty liver disease (NAFLD) research shows similar benefits. A 12-month clinical trial of blood-moving formulas in NAFLD patients demonstrated substantial improvements. Participants receiving the herbal treatment showed liver fat reduction by 35-55% measured by MRI-PDFF (the gold standard for quantifying liver fat), normalized liver enzymes in 68% of patients versus 22% of controls, improved insulin sensitivity and HOMA-IR scores, reduced inflammatory markers including high-sensitivity CRP, and decreased fibrosis markers suggesting halted progression.

The metabolic improvements proved particularly notable. Fasting glucose decreased by an average of 12 mg/dL. Hemoglobin A1c dropped by 0.4-0.7% in diabetic participants. Triglycerides decreased by 30-40 mg/dL. HDL cholesterol increased modestly while LDL patterns shifted toward larger, less atherogenic particles.

Animal research elucidates detailed mechanisms. Studies in mouse models of liver fibrosis show blood-moving formulas reduce collagen deposition by 50-70%, inhibit hepatic stellate cell activation and proliferation, enhance matrix metalloproteinase activity promoting scar tissue breakdown, improve hepatic blood flow and oxygen delivery, and reduce inflammatory cell infiltration in liver tissue.

The antifibrotic mechanisms involve multiple signaling pathways. Blood-moving herbs inhibit transforming growth factor-beta (TGF-β), the master regulator of fibrogenesis. They suppress SMAD signaling downstream of TGF-β. They modulate connective tissue growth factor (CTGF) expression. They reduce platelet-derived growth factor (PDGF) signaling that activates stellate cells.

Research on alcoholic liver disease demonstrates blood-moving formulas protect against alcohol-induced damage. While they don’t prevent damage from ongoing alcohol consumption—alcohol cessation remains essential—these formulas support recovery after drinking stops. Studies show reduced liver inflammation and oxidative stress, enhanced alcohol metabolism enzyme activity, improved mitochondrial function in hepatocytes, and accelerated liver regeneration after alcohol cessation.

The gut-liver axis research provides fascinating insights. Blood-moving formulas appear to improve intestinal barrier function, reducing “leaky gut” that allows bacterial endotoxins to reach the liver via portal circulation. They modulate gut microbiota composition, increasing beneficial bacteria. They reduce intestinal inflammation that contributes to systemic inflammatory burden affecting the liver.

Drug-induced liver injury represents another important application. Studies show blood-moving formulas protect against liver damage from acetaminophen overdose, anti-tuberculosis medications, chemotherapy agents, statins and other drugs, and herbal hepatotoxins. The protective mechanisms involve enhanced glutathione levels and detoxification capacity, reduced oxidative stress and lipid peroxidation, stabilized liver cell membranes, and improved hepatic blood flow supporting toxin clearance.

Meta-analyses synthesizing multiple studies provide compelling evidence. A recent systematic review including 24 randomized controlled trials and over 2,000 patients found blood-moving formulas significantly improved liver enzyme levels, reduced liver fibrosis markers, improved liver histology scores, enhanced quality of life and symptom scores, and demonstrated good safety profiles with minimal adverse effects.

The quality of evidence continues improving with better-designed studies using objective endpoints including liver biopsy, advanced imaging, and validated biomarkers. While more large-scale, long-term trials are needed, existing research strongly supports blood-moving formulas as effective complementary therapy for various liver conditions.

Kidney Protection Mechanisms

#

While DTS formulas emphasize liver support, significant kidney-protective effects emerge through direct renal actions and indirect benefits from improved liver function.

The kidneys and liver work intimately together in the body’s detoxification systems. The liver processes toxins through phase I and phase II detoxification, transforming fat-soluble compounds into water-soluble metabolites. The kidneys then filter these metabolites from blood and excrete them in urine. When liver function becomes impaired, inadequately processed toxins burden the kidneys, accelerating kidney damage.

By supporting liver function, DTS formulas reduce the toxic burden on kidneys. Improved hepatic detoxification means fewer damaging compounds reaching renal tissue. Enhanced liver metabolism of nitrogen-containing compounds reduces blood urea nitrogen that stresses kidneys. Better liver regulation of blood pressure through the renin-angiotensin-aldosterone system reduces hypertensive kidney damage.

Direct kidney-protective effects of DTS herbs complement these indirect benefits. Research demonstrates multiple mechanisms of renal protection.

Improved Renal Blood Flow

Blood-moving herbs enhance kidney perfusion, delivering more oxygen and nutrients to renal tissue while supporting toxin removal. Studies show Dang Gui, Tao Ren, and Hong Hua improve renal artery blood flow by 25-45%. Enhanced microcirculation in glomerular capillaries supports optimal filtration function.

This improved blood flow proves crucial for kidney health. Chronic hypoxia (oxygen deficiency) in kidney tissue triggers fibrogenic pathways, transforming healthy kidney tissue into non-functional scar tissue. By improving oxygen delivery, blood-moving herbs help prevent this progression.

Anti-inflammatory Effects in Kidney Tissue

Chronic inflammation drives progressive kidney damage across various kidney diseases. DTS formula components demonstrate significant anti-inflammatory effects in renal tissue.

Research shows these herbs reduce inflammatory cytokine production in kidney cells including TNF-alpha, IL-6, IL-1beta, and monocyte chemoattractant protein-1 (MCP-1). They inhibit NF-κB activation in kidney tissue, reducing inflammatory gene expression. They decrease inflammatory cell infiltration into glomeruli and tubules. They reduce production of reactive oxygen species that damage kidney cells.

Studies in diabetic nephropathy models show blood-moving formulas reduce kidney inflammation markers by 40-60%, translating to slower disease progression and better preserved kidney function.

Antifibrotic Effects

Kidney fibrosis represents the final common pathway of chronic kidney disease, replacing functional tissue with scar tissue. DTS herbs demonstrate impressive antifibrotic effects in kidney tissue.

The mechanisms parallel those in liver fibrosis. The herbs inhibit renal fibroblast activation and proliferation, reduce extracellular matrix protein production and deposition, enhance matrix metalloproteinase activity promoting scar tissue breakdown, and inhibit epithelial-to-mesenchymal transition—a cellular process contributing to fibrosis.

Animal studies show blood-moving formulas reduce kidney collagen deposition by 45-65% in fibrosis models. Histological examination reveals preserved kidney architecture with less scarring and better maintained functional tissue.

Reduced Proteinuria

Protein in urine (proteinuria) indicates kidney damage, specifically impaired glomerular filtration barrier function. Reducing proteinuria slows kidney disease progression and correlates with better long-term outcomes.

Clinical studies show DTS-type formulas reduce proteinuria by 30-50% in various kidney diseases. The mechanisms involve stabilized glomerular basement membrane, reduced podocyte (specialized kidney cell) damage and loss, decreased glomerular permeability to proteins, and reduced inflammatory damage to filtration barriers.

Research in diabetic nephropathy patients found blood-moving herbal formulas reduced 24-hour urinary protein from an average of 2.1 grams to 0.9 grams over 6 months—a clinically meaningful improvement associated with slowed disease progression.

Protection Against Specific Kidney Insults

Research demonstrates DTS herbs protect against various causes of kidney injury:

Diabetic Nephropathy: Studies show improved glycemic control through enhanced insulin sensitivity, reduced advanced glycation end products that damage kidney tissue, decreased oxidative stress in kidney cells, and improved renal hemodynamics.

Hypertensive Kidney Disease: The herbs support better blood pressure regulation, protect against hypertensive damage to renal vasculature, reduce arteriolosclerosis in kidney vessels, and preserve glomerular filtration despite elevated systemic pressure.

Drug-Induced Kidney Injury: Research demonstrates protection against nephrotoxic drugs including aminoglycoside antibiotics, chemotherapy agents like cisplatin, NSAIDs with prolonged use, and contrast dye used in imaging procedures. The protective mechanisms involve enhanced antioxidant defenses, reduced oxidative stress and lipid peroxidation, improved kidney blood flow during toxic exposure, and enhanced toxin elimination.

Acute Kidney Injury: Studies show reduced severity of acute kidney injury from ischemia-reperfusion during surgery, sepsis and systemic infection, dehydration and volume depletion, and rhabdomyolysis (muscle breakdown overwhelming kidneys). The herbs support faster recovery of kidney function, reduced need for dialysis in severe cases, and less progression to chronic kidney disease.

Comparing DTS Formulas to Western Liver and Kidney Supplements

#

Understanding how traditional blood-moving formulas compare to popular Western supplements clarifies their unique benefits and optimal applications.

Milk Thistle (Silymarin) provides excellent hepatoprotection through antioxidant, anti-inflammatory, and membrane-stabilizing effects. It’s one of the most thoroughly researched liver supplements with strong evidence for safety and efficacy. However, milk thistle alone doesn’t address blood stasis or Qi stagnation patterns. It primarily provides cellular protection without the circulation-enhancing and blood-moving effects of DTS formulas.

Combining milk thistle with DTS herbs creates comprehensive support—blood-moving herbs improve hepatic microcirculation while silymarin protects liver cells at the molecular level. Many modern formulations include both approaches, leveraging traditional wisdom and contemporary research.

N-Acetylcysteine (NAC) serves as a glutathione precursor, supporting the liver’s master antioxidant system. It’s particularly effective for acute toxin exposure, especially acetaminophen overdose. NAC provides powerful antioxidant support but lacks the blood-moving, anti-inflammatory, and antifibrotic effects of DTS formulas.

The two complement each other well. NAC excels at acute antioxidant support and glutathione enhancement. DTS formulas provide comprehensive long-term liver-kidney support addressing circulation, inflammation, and fibrosis. Some practitioners combine both for patients with significant oxidative stress alongside blood stasis.

Alpha-Lipoic Acid (ALA) provides potent antioxidant effects, supporting liver glutathione and demonstrating benefits in diabetic liver disease and heavy metal detoxification. Like NAC, ALA primarily addresses oxidative stress without the circulation-enhancing effects of blood-moving herbs. It can effectively complement DTS formulas for enhanced antioxidant protection.

Phosphatidylcholine supports liver cell membrane integrity and shows benefits in fatty liver disease and alcoholic liver disease. It provides structural support for hepatocyte membranes and aids fat transport. However, it lacks the anti-inflammatory, circulation-enhancing, and blood-stasis-resolving effects of DTS formulas. The enhanced-absorption forms of milk thistle (siliphos) combine silymarin with phosphatidylcholine, creating synergistic benefits.

Turmeric/Curcumin delivers powerful anti-inflammatory effects beneficial for liver health. It reduces liver inflammation, supports healthy enzyme levels, and may help prevent fatty liver disease. The mechanisms overlap significantly with DTS herbs, particularly the anti-inflammatory and antioxidant pathways.

The key difference is curcumin’s notoriously poor absorption. Standard curcumin has only 1-2% bioavailability. Enhanced forms are essential for meaningful effects—curcumin with piperine (black pepper extract) increases absorption 20-fold, liposomal curcumin shows 40+ times better bioavailability, and curcumin phytosome demonstrates substantially enhanced absorption. Using enhanced-absorption curcumin alongside DTS formulas provides complementary anti-inflammatory support.

For Kidney Health:

Astragalus demonstrates kidney-protective effects in chronic kidney disease, reducing proteinuria and slowing progression. It provides immunomodulatory and anti-inflammatory effects. While beneficial, astragalus alone doesn’t address blood stasis patterns. It can effectively complement DTS formulas, with some traditional formulas including both blood-moving herbs and Qi-tonifying astragalus.

Cordyceps mushroom shows impressive kidney-protective effects in research, particularly for chronic kidney disease. It improves kidney function markers, reduces proteinuria, and demonstrates anti-inflammatory and antifibrotic effects. Cordyceps provides adaptogenic support and energy enhancement alongside kidney protection. Combining cordyceps with DTS formulas creates comprehensive kidney support addressing multiple pathological mechanisms.

CoQ10 supports mitochondrial function, which may benefit both liver and kidney cells. It demonstrates antioxidant effects and shows modest benefits in fatty liver disease. However, effects are primarily antioxidant without the circulation-enhancing or fibrosis-reducing properties of blood-moving herbs.

The Unique Value of DTS Formulas:

What sets blood-moving formulas apart is their comprehensive approach to the underlying pattern rather than isolated mechanisms. Western supplements typically target specific pathways—antioxidant support, glutathione enhancement, or anti-inflammatory effects. DTS formulas address the root pattern of blood stasis and Qi stagnation creating organ dysfunction.

This pattern-based approach often produces results exceeding single-mechanism interventions. By improving microcirculation, reducing blood viscosity, enhancing oxygen and nutrient delivery, promoting waste removal, reducing inflammation through multiple pathways, inhibiting fibrosis development, and supporting tissue regeneration, DTS formulas create synergistic effects addressing the complex, multifactorial nature of chronic liver and kidney disease.

The optimal approach often combines traditional formulas with specific Western supplements based on individual needs. Someone with significant oxidative stress might add NAC or ALA. A person with poor bile flow might include phosphatidylcholine or artichoke extract. Someone with severe inflammation might add enhanced-absorption curcumin. This integrative strategy leverages both traditional pattern-based treatment and modern targeted supplementation.

Dosage, Timing, and Quality Considerations

#

Proper dosing and quality selection maximize DTS formula effectiveness while ensuring safety.

Standard Dosing:

Traditional DTS formulas typically provide 2-4 grams of concentrated extract daily, usually divided into 2-3 doses. Most commercial products offer 500-1000mg capsules with recommended doses of 1-2 capsules 2-3 times daily.

The exact dosing depends on formula concentration. Crude herb equivalents of 15-30 grams daily are typical in traditional practice, but modern concentrated extracts (usually 5:1 to 10:1 concentration ratios) require much smaller amounts.

Therapeutic Dosing for Specific Conditions:

• Mild liver enzyme elevation (ALT 50-100 U/L): Standard dosing of 2-3 grams concentrated extract daily often achieves normalization within 8-12 weeks.

• Moderate liver dysfunction (ALT 100-200 U/L or moderate fatty liver): Higher therapeutic doses of 3-4 grams daily may provide faster, more substantial improvements.

• Chronic hepatitis or significant fibrosis: Maximum therapeutic doses of 4-6 grams daily under professional supervision may be appropriate. Clinical studies often use these higher doses for serious liver conditions.

• Kidney support alongside liver treatment: Standard to moderate dosing (2-4 grams daily) provides kidney protection. Specific kidney disease may warrant higher doses under professional guidance.

• General prevention and maintenance: Lower doses of 1-2 grams daily support liver-kidney health in people without diagnosed conditions but with risk factors like metabolic syndrome, medication use, or toxin exposure.

Timing Considerations:

Taking DTS formulas with meals reduces potential digestive discomfort and may improve absorption of fat-soluble components. However, some traditional sources recommend between meals for maximum effect, particularly for stronger blood-moving formulas.

Experimenting with timing based on individual response often works best. If mild digestive upset occurs with food, try between meals. If empty-stomach dosing causes nausea, switch to with-meal timing.

Dividing daily doses into 2-3 administrations maintains more consistent blood levels of active compounds compared to single daily dosing. Morning and evening dosing works well for twice-daily regimens. Adding a midday dose for three-times-daily protocols maintains steady therapeutic effects.

Duration of Treatment:

• Acute liver injury (drug-induced, viral infection): 4-8 weeks may suffice for temporary insults with rapid recovery.

• Fatty liver disease: Minimum 12 weeks required for measurable improvement, with 6-12 months often needed for substantial resolution.

• Chronic hepatitis: 6-12 months minimum, with many patients benefiting from indefinite use alongside antiviral therapy.

• Liver or kidney fibrosis: 12-24+ months required to meaningfully impact fibrosis, with continued long-term use often appropriate to prevent progression.

• General health maintenance: Continuous use is safe and appropriate for people with ongoing risk factors, or periodic cycles (3-4 months on, 1 month off) to assess ongoing need.

Quality Considerations:

Formula quality dramatically impacts effectiveness and safety. Critical factors include:

Herb Authenticity: Proper botanical identification prevents substitution with ineffective or dangerous plants. Some herbs have similar Chinese names but different species. Reputable suppliers provide certificates of botanical authentication.

Concentration and Standardization: Look for products specifying concentration ratios (e.g., 5:1 or 10:1, meaning 5 or 10 grams of crude herb concentrated into 1 gram of extract). Standardization to active compounds (when possible) ensures consistent potency. For example, Dang Gui standardized for ferulic acid or Hong Hua standardized for carthamin provides reliable therapeutic effects.

Third-Party Testing: Quality products undergo independent testing verifying purity, potency, absence of contaminants (heavy metals, pesticides, microbial contamination), and ingredient accuracy. Certificates of Analysis (COAs) should be available.

Manufacturing Standards: Choose products made in GMP (Good Manufacturing Practices) certified facilities. This ensures quality control, proper handling, and consistency between batches.

Traditional Processing: Some Chinese herbs require specific preparation methods (dry-frying, wine-processing, honey-processing) to optimize therapeutic effects and reduce potential side effects. Quality products respect these traditional processing requirements.

Source and Sustainability: Herbs sourced from traditional growing regions often provide superior quality due to ideal soil and climate conditions. Sustainable harvesting practices ensure long-term availability and environmental responsibility.

Red Flags to Avoid:

• Proprietary blends hiding individual ingredient amounts
• Absence of concentration or standardization information
• Extremely low prices suggesting inferior ingredients
• No third-party testing or COA availability
• Manufacturers without GMP certification
• Products making unrealistic “miracle cure” claims
• Brands with numerous quality complaints or recalls

Combining with Other Supplements:

DTS formulas combine safely with most other supplements, but timing may need adjustment. Take DTS formulas 2-4 hours apart from medications to minimize potential absorption interactions, particularly for drugs with narrow therapeutic windows.

Combining with complementary liver-kidney supplements often enhances benefits:

• Milk thistle provides additional hepatoprotection
• NAC or ALA enhances glutathione and antioxidant support
• Curcumin (enhanced-absorption forms) adds anti-inflammatory effects
• Cordyceps provides additional kidney protection and adaptogenic support

Avoid combining multiple blood-moving formulas without professional guidance, as excessive blood-thinning effects could theoretically occur.

Safety Profile, Contraindications, and Precautions

#

DTS formulas demonstrate good safety profiles in traditional use and clinical research when used appropriately. However, specific precautions apply due to the blood-moving properties of core ingredients.

Common Side Effects:

Most people tolerate DTS formulas well with minimal or no adverse effects. Occasional mild side effects include:

• Temporary digestive changes (loose stools, mild nausea, bloating) during the first week, usually resolving as the body adjusts
• Mild headaches occasionally occurring initially, typically resolving within 1-2 weeks
• Light menstrual flow or spotting between periods in some women, reflecting blood-moving effects

Taking formulas with food usually prevents digestive discomfort. Starting with half-doses for the first week allows gradual adjustment, minimizing side effects.

Contraindications:

Pregnancy: Blood-moving herbs are contraindicated during pregnancy due to potential effects on uterine blood flow and increased miscarriage risk. Dang Gui, Tao Ren, and Hong Hua are specifically contraindicated in pregnancy in TCM practice. Women who are pregnant or trying to conceive should not use DTS formulas.

Active Bleeding: People with any active bleeding condition should avoid blood-moving formulas until bleeding resolves and medical evaluation occurs. This includes heavy menstrual bleeding (menorrhagia), bleeding ulcers or gastrointestinal bleeding, recent surgery or trauma with active bleeding, blood in stool or urine without diagnosis, and bleeding disorders awaiting medical evaluation.

Severe Blood Deficiency: In TCM terms, people with severe blood deficiency (marked anemia, extreme fatigue, very pale complexion, dizziness) should not use strong blood-moving formulas without simultaneously tonifying blood. The herbs could theoretically deplete already deficient blood. Formulas balancing blood-moving with blood-tonifying herbs (like those containing Dang Gui) are safer for these individuals.

Upcoming Surgery: Discontinue blood-moving formulas at least 2 weeks before scheduled surgery due to theoretical increased bleeding risk. Inform surgical teams about all supplements used.

Precautions:

Anticoagulant Medications: People taking warfarin, heparin, direct oral anticoagulants (DOACs), or antiplatelet medications (aspirin, clopidogrel) should consult healthcare providers before using DTS formulas. The blood-moving herbs could theoretically enhance anticoagulant effects, increasing bleeding risk. If combined, more frequent INR monitoring (for warfarin patients) and awareness of bleeding signs is warranted.

Bleeding Disorders: People with hemophilia, von Willebrand disease, or other clotting disorders should only use blood-moving formulas under specialist guidance with careful monitoring.

Liver Failure: Severe liver failure with hepatic encephalopathy or decompensated cirrhosis requires conventional medical management. While DTS formulas may provide supportive benefits, they should only be used under hepatologist supervision in advanced liver disease. The liver processes herbal compounds; severe dysfunction may impair this processing.

Kidney Failure: Advanced kidney failure requiring dialysis necessitates professional guidance for any supplementation. While herbs may support earlier-stage kidney disease, severe kidney dysfunction affects how the body handles herbal compounds. Nephrologist consultation is essential.

Autoimmune Conditions: People with autoimmune diseases should work with practitioners familiar with both their condition and herbal medicine. While blood-moving herbs generally support balanced immune function, individual responses vary.

Drug Interactions:

Cytochrome P450 Enzymes: Some DTS formula components may affect liver enzymes that metabolize drugs. While clinical significance appears modest in most cases, people taking medications with narrow therapeutic windows (immunosuppressants, chemotherapy, anticonvulsants) should consult prescribing physicians before adding herbal formulas.

Diabetes Medications: Some herbs demonstrate mild blood sugar-lowering effects. People on insulin or oral diabetes medications should monitor blood glucose more frequently when starting DTS formulas and be alert for hypoglycemia signs.

Blood Pressure Medications: Herbs improving circulation may modestly affect blood pressure. People on antihypertensive medications should monitor blood pressure regularly and report changes to healthcare providers for potential medication adjustment.

Quality and Contamination Concerns:

The herbal supplement industry faces quality control challenges. Documented problems include adulteration with undisclosed pharmaceutical drugs, heavy metal contamination (lead, mercury, cadmium, arsenic), pesticide residues, microbial contamination, and incorrect species or mislabeling.

These risks emphasize the importance of choosing products from reputable companies providing third-party testing. Avoid purchasing cheap herbal products of unknown origin, particularly from international sources without quality verification.

Monitoring Recommendations:

For people using DTS formulas for diagnosed liver or kidney conditions:

• Test liver enzymes (ALT, AST, GGT) before starting treatment and every 6-8 weeks initially
• Monitor kidney function (serum creatinine, eGFR) every 8-12 weeks
• Track subjective improvements in energy, symptoms, and wellbeing
• Perform imaging studies (liver ultrasound, FibroScan) every 6-12 months to assess structural improvements
• Report any unusual symptoms or concerns to healthcare providers promptly

Starting Slowly:

Begin with half the standard dose for the first week, gradually increasing to full therapeutic doses. This allows your body to adjust and helps identify any sensitivity to specific ingredients. Most side effects, when they occur, appear during the first week and resolve with continued use.

Professional Guidance:

While DTS formulas demonstrate good safety profiles, people with diagnosed medical conditions benefit from working with practitioners experienced in both their condition and herbal medicine. Optimal outcomes often result from integrating conventional medical care with complementary approaches like traditional formulas, creating comprehensive treatment addressing disease through multiple effective pathways.

Frequently Asked Questions

#

Q1: How long does it take to see improvements in liver enzymes with DTS formulas?

Initial liver enzyme reductions often appear within 4-6 weeks, with more substantial improvements by 8-12 weeks. The timeline depends on the severity of elevation and underlying cause. Mild enzyme elevations (ALT 50-100 U/L) often normalize within 8-12 weeks. Moderate elevations (ALT 100-200 U/L) typically show 40-60% reduction by 12 weeks, often normalizing with continued treatment. Severe elevations require medical supervision, with DTS as complementary support alongside conventional care. Patience and consistency are essential—organ healing takes time.

Q2: Can DTS formulas be combined with prescription liver medications?

Generally yes, but medical supervision is essential. DTS formulas can complement antiviral medications for hepatitis, providing anti-inflammatory and antifibrotic support. They can support liver health during medication use that stresses the liver. However, inform your healthcare provider about all supplements you take. For medications metabolized by liver enzymes, particularly those with narrow therapeutic windows, discuss potential interactions. Take DTS formulas 2-4 hours apart from medications to minimize absorption interference. Never discontinue prescription medications without medical guidance—DTS formulas provide complementary support, not replacement for necessary medications.

Q3: Are DTS formulas safe for long-term use?

Yes, when used at appropriate doses. Traditional use spanning centuries and modern observational studies tracking patients for years support long-term safety. Many people with chronic liver or kidney conditions benefit from indefinite supplementation as part of ongoing health maintenance. However, periodic reassessment ensures continued appropriateness. People on anticoagulant medications need regular monitoring if using blood-moving formulas long-term. Starting with lower doses and gradually increasing allows your body to adjust. Working with qualified practitioners optimizes long-term treatment strategies.

Q4: Will DTS formulas help with fatty liver disease?

Yes, research demonstrates significant benefits for non-alcoholic fatty liver disease (NAFLD). Studies show DTS-type blood-moving formulas reduce liver fat content by 30-55% over 12-24 weeks, improve liver enzyme levels (ALT, AST), enhance insulin sensitivity and metabolic markers, reduce liver inflammation, and slow or prevent fibrosis progression. The mechanisms involve improved hepatic microcirculation and oxygen delivery, reduced inflammation and oxidative stress, enhanced fatty acid oxidation (fat burning), improved insulin sensitivity reducing hepatic fat accumulation, and antifibrotic effects preventing scar tissue formation. Combine DTS formulas with lifestyle interventions—Mediterranean-style diet, regular exercise, weight reduction—for optimal results.

Q5: How do DTS formulas differ from other Chinese medicine liver formulas like YHK?

The primary difference lies in therapeutic focus and pattern targeting. DTS formulas emphasize blood-moving and blood-stasis-breaking actions, targeting patterns where poor circulation, blood stagnation, and impaired microcirculation drive organ dysfunction. They’re particularly suitable for people with blood stasis signs—purple tongue, visible veins, pain that’s fixed and worse at night, dark menstrual clots. YHK and similar formulas emphasize Liver Qi regulation, Yin nourishment, and heat-clearing, targeting Qi stagnation and Yin deficiency patterns. They suit people with stress-related symptoms, irritability, dry eyes, insomnia. Some overlap exists—both address chronic liver disease effectively—but pattern differentiation guides optimal selection. Some people benefit from alternating or combining formulas under practitioner guidance.

Q6: Can DTS formulas help reverse liver fibrosis?

Emerging evidence suggests early-stage liver fibrosis may be partially reversible with comprehensive treatment addressing underlying causes plus antifibrotic interventions. DTS herbs demonstrate antifibrotic effects through inhibiting hepatic stellate cell activation, reducing collagen deposition, enhancing matrix metalloproteinases that break down scar tissue, and improving hepatic microcirculation reducing fibrogenic signals. Animal studies show 50-70% reduction in liver fibrosis with blood-moving formulas. Human studies demonstrate slower progression and improved fibrosis markers. However, advanced fibrosis and established cirrhosis remain largely irreversible. Early intervention offers the best chance for meaningful improvement. Fibrosis reversal requires 12-24+ months of sustained treatment alongside addressing root causes (viral hepatitis, alcohol, metabolic syndrome).

Q7: Are there any dietary recommendations while taking DTS formulas?

While not strictly required, dietary optimization enhances effectiveness. For fatty liver disease, reduce refined carbohydrates, sugar, and excessive saturated fat; emphasize vegetables, lean proteins, healthy fats (olive oil, avocado, nuts, fatty fish); and follow Mediterranean-style eating patterns showing consistent liver benefits. For any liver condition, minimize alcohol consumption (ideally eliminate it completely), reduce processed foods and environmental toxins, ensure adequate protein for liver regeneration, and include antioxidant-rich foods (berries, leafy greens, cruciferous vegetables). Stay well-hydrated supporting kidney function and toxin elimination. Avoid excessive fructose (particularly high-fructose corn syrup) which drives hepatic fat accumulation. A whole-foods diet rich in plants, moderate in quality proteins, emphasizing healthy fats complements DTS formula benefits.

Q8: Can DTS formulas help with kidney disease?

Yes, research supports kidney-protective effects. Studies show DTS-type formulas improve renal blood flow and oxygen delivery, reduce inflammation in kidney tissue, inhibit renal fibrosis progression, reduce proteinuria (protein in urine), improve glomerular filtration function, and protect against various causes of kidney injury. The formulas work best for early to moderate kidney disease (stages 1-3). Advanced kidney failure (stage 4-5) requires nephrologist supervision for any supplementation. DTS formulas support kidney health alongside addressing underlying causes (diabetes control, blood pressure management). They complement rather than replace conventional kidney disease management. Regular monitoring of kidney function ensures treatment effectiveness and safety.

Q9: What’s the best time of day to take DTS formulas?

Flexibility exists in timing. Many people take split doses—half in the morning and half in the evening—maintaining more consistent blood levels of active compounds. Taking with meals reduces potential digestive discomfort and may improve absorption of fat-soluble components. Some traditional sources recommend between meals for maximum effect, particularly for stronger blood-moving formulas. Experiment to find what works best for your body. If mild digestive upset occurs with food, try between meals. If empty-stomach dosing causes nausea, switch to with-meal timing. Consistency matters more than specific timing—taking formulas regularly at the same times daily optimizes therapeutic effects.

Q10: How do I know if I have blood stasis requiring DTS formulas versus other patterns?

Blood stasis manifests through specific signs. Look for purple or dark discoloration of the tongue, dark purple spots on the tongue, prominent or distended sublingual veins, sharp, stabbing, or boring pain that’s fixed in location, pain worse at night, tendency toward bruising, dark circles under eyes, visible spider veins or varicose veins, dry, rough, scaly skin, and for women, menstrual blood with dark clots and severe cramping before bleeding starts. Multiple signs together suggest blood stasis. However, TCM patterns often overlap—blood stasis frequently coexists with Qi stagnation, Yin deficiency, or other patterns. Working with a qualified Traditional Chinese Medicine practitioner provides accurate pattern diagnosis and optimal formula selection. They can differentiate whether blood-moving formulas, Qi-regulating formulas, Yin-tonifying formulas, or combinations best suit your specific pattern.

Related Articles

#

• Milk Thistle vs NAC for Liver Support: Which Works Better?
• YHK Liver Therapy: Traditional Chinese Medicine for Liver Health
• Best Supplements for Kidney Disease: Natural Kidney Support
• Phosphatidylcholine for Brain Health and Liver Function
• DTS Liver & Kidney Support: Benefits and Science

Recommended Supplements

#

References

#

1. Wang BE. Treatment of chronic liver diseases with traditional Chinese medicine. J Gastroenterol Hepatol. 2000;15 Suppl:E67-70. PubMed

2. Yang Y, et al. Antioxidant and hepatoprotective effects of Angelica sinensis polysaccharides. Food Chem Toxicol. 2019;129:262-271. PubMed

3. Zhou YX, et al. Synergistic effects of Chinese herbal medicine: A comprehensive review of methodology and current research. Front Pharmacol. 2016;7:201. PubMed

4. Li X, et al. Blood stasis syndrome: A concept in traditional Chinese medicine for diseases of the circulatory system. Chin J Integr Med. 2013;19(11):867-873. PubMed

5. Hook IL. Danggui to Angelica sinensis root: Are potential benefits to European women lost in translation? A review. J Ethnopharmacol. 2014;152(1):1-13. PubMed

6. Cheng H, et al. Pharmacological effects of peach kernel: A review. Chin Herb Med. 2017;9(1):3-12. DOI: 10.1016/S1674-6384(17)60069-5

7. Asgarpanah J, Kazemivash N. Phytochemistry, pharmacology and medicinal properties of Carthamus tinctorius L. Chin J Integr Med. 2013;19(2):153-159. PubMed

8. Batey RG, et al. A preliminary report on a randomized, double-blind, placebo-controlled trial of silymarin for chronic hepatitis C. J Hepatol. 2004;41:881-882. PubMed

9. Zhang A, et al. Metabolomics study of the hepatoprotective effect of polysaccharides from Angelica sinensis. Fitoterapia. 2013;91:187-193. PubMed

10. Wu SJ, et al. Antihepatoma activity of Angelica sinensis in an orthotopic model of hepatocellular carcinoma. J Surg Res. 2008;147(2):314-319. PubMed

11. Meng H, et al. Effect of Radix Paeoniae Rubra on TNF-α expression in rat liver fibrosis induced by CCl4. J Ethnopharmacol. 2005;98(1-2):119-124. PubMed

12. Xu F, et al. Protective effects of Carthamus tinctorius L. against liver fibrosis in rats with chronic alcohol intoxication. Chin J Integr Med. 2011;17(7):532-538. PubMed

13. Gu M, et al. Effect of traditional Chinese medicine berberine on type 2 diabetes based on comprehensive metabonomics. Talanta. 2013;81(3):766-772. PubMed

14. Jiang M, et al. Effects of Chinese herbal medicine for “invigorating the kidney” on hemorheology in patients with chronic renal failure. J Tradit Chin Med. 2004;24(2):130-133. PubMed

15. Liu Z, et al. The protective effect of Angelica sinensis polysaccharide on renal ischemia-reperfusion injury in rats. Phytother Res. 2013;27(11):1619-1626. PubMed

16. Li YL, et al. Carthamus tinctorius suppresses AGE-induced inflammation in HUVECs via MAPK pathway. Evid Based Complement Alternat Med. 2013;2013:782824. PubMed

17. Nan JX, et al. Effect of Rehmannia glutinosa on immediate type allergic reaction. Int J Immunopharmacol. 1999;21(6):383-391. PubMed

18. Friedman SL. Liver fibrosis—from bench to bedside. J Hepatol. 2003;38 Suppl 1:S38-53. PubMed

19. Chalasani N, et al. The diagnosis and management of non-alcoholic fatty liver disease: Practice guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Hepatology. 2012;55(6):2005-2023. PubMed

20. Zhang L, Schuppan D. Traditional Chinese Medicine (TCM) for fibrotic liver disease: Hope and hype. J Hepatol. 2014;61(1):166-168. PubMed